251 results on '"Klingberg, Eva"'
Search Results
2. Gender differences in illness perceptions and disease management in patients with gout, results from a questionnaire study in Western Sweden
3. The impact of a structured weight-loss treatment on physical fitness in patients with psoriatic arthritis and obesity compared to matched controls: a prospective interventional study
4. The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)
5. The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)
6. Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study.
7. Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study
8. Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up
9. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
10. Sex differences in cytokines and adipokines in obese patients with PsA and controls undergoing a weight loss intervention.
11. The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)
12. The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden 2017
13. Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden
14. The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017
15. The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)
16. Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis : an observational nationwide study
17. Aortic Regurgitation Is Common in Ankylosing Spondylitis: Time for Routine Echocardiography Evaluation?
18. Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex
19. A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis
20. The Impact of Immunomodulating Treatment on the Immunogenicity of COVID-19 Vaccines in Patients with Immune-mediated Inflammatory Rheumatic Diseases Compared to Healthy Controls. a Swedish Nationwide Study (COVID19-REUMA)
21. Seasonal variations in serum 25-hydroxy vitamin D levels in a Swedish cohort
22. Comment on: Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA: results from a national register-based cohort study. Reply
23. Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden
24. Comment on: Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA: : results from a national register-based cohort study. Reply
25. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
26. Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis
27. Additional file 1 of Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up
28. Gut Microbiome Changes Are Different Between Ankylosing Spondylitis and Inflammatory Bowel Disease, and Correlate with Disease Activity in Both Diseases
29. The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden 2017
30. Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci
31. Genomewide association study of acute anterior uveitis identifies new susceptibility loci
32. Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study
33. Elevated levels of Wnt3a and low levels of Dickkopf-1 in serum are associated with syndesmophyte formation in ankylosing spondylitis
34. Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis
35. Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up
36. Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci
37. Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study
38. Additional file 1: of Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study
39. MOESM1 of A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
40. Cardiac conduction disturbances in patients with ankylosing spondylitis : results from a 5-year follow-up cohort study
41. Incidence of extra-articular manifestations in ankylosing spondylitis, proriatic arthritis and undifferentiated spondyloarthritis - results from a national register-based cohort study
42. Hepatocyte growth factor is a predictor of development of new syndesmophytes in men with ankylosing spondylitis. A five year prospective study
43. Weight loss improves disease activity in patients with psoriatic arthritis and obesity : an interventional study
44. Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study.
45. Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study
46. Additional file 1: of Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex
47. SAT0323 HEPATOCYTE GROWTH FACTOR IS A PREDICTOR OF DEVELOPMENT OF NEW SYNDESMOPHYTES IN MEN WITH ANKYLOSING SPONDYLITIS. A FIVE YEAR PROSPECTIVE STUDY
48. SAT0317 INCIDENCE OF EXTRA-ARTICULAR MANIFESTATIONS IN ANKYLOSING SPONDYLITIS, PSORIATIC ARTHRITIS AND UNDIFFERENTIATED SPONDYLOARTHRITIS – RESULTS FROM A NATIONAL REGISTER-BASED COHORT STUDY
49. AB1257 CARDIOVASCULAR RISK FACTORS IN GOUT COMPARED TO AS, PSA AND RA – RESULTS FROM A QUESTIONNAIRE STUDY
50. OP0008 SUSTAINED LOW DISEASE ACTIVITY AFTER WEIGHT LOSS TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS AND OBESITY; A 12-MONTHS FOLLOW-UP
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.